21 results
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
commonly used drugs ... for tuberculosis ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 4/11/2020 #Drugs ... #COVID19 #Pharmacology ... #Table #Management
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of Drugs ... for Treatment of ... #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... Class Overview ... B for initial management ... - Drug levels ... #Pharmacology #Antibiotics
Oral Antibiotics for Acne - Indicated for Moderate-to-Severe Acne 
First-Line Drug Class: Tetracyclines 

In the last
Acne First-Line Drug ... reviewed mild acne treatment ... specifically for acne treatment ... #Pharmacology # ... Management #Dermatology
Migraine Treatment Overview

 • What is a Migraine?
 • Pathophysiology
 • Common Migraine Triggers
 • Diagnosis
Migraine Treatment ... Overview • ... Diagnosis • Non-Drug ... Treatment: • ... #management #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Resistant Tuberculosis ... #MDRTB #management ... #Treatment #antimicrobials ... #regimens #pharmacology
Glaucoma is a condition that involves an increase in pressure inside the eye. It occurs when
pressure inside the eye ... drain out of the eye ... glaucoma and is the drug ... glaucoma #pharmacology ... #treatment #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... inhibitors • Injection drug ... Treatment: Active ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... inhibitors • Injection drug ... Treatment: Active ... TB #Diagnosis #Management ... #Treatment #ActiveTB